Artificial Organs are synthetic implants that are unified in human body to imitate the function of an original organ. They are usually composed of the stem cells seeded plastic from the transplant recipient and thus the body's immune system does not reject the artificial organ.
MARKET DYNAMICS
The Artificial Organs market is anticipated to grow in the forecast, owing to the factors such as rapid increase in ageing global population, growing prevalence of people suffering from failed organs, frequent road accidents and injuries, public awareness about advancements in medical technology and lack of organ donors. Nevertheless, high cost of implantation and limited surgical expertise are expected to restrict the growth of market during the forecast period.
MARKET SCOPE
The "Global Artificial Organs Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Artificial Organs market with detailed market segmentation by product type, method of fixation, technology and geography. The global Artificial Organs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Artificial Organs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Artificial Organs market is segmented on the basis of product, method of fixation and technology. Based on product the type the market is segmented into artificial heart, artificial kidney, artificial liver, artificial pancreas, artificial lungs, others. Based on method of fixation the market is segmented into implantable, externally worn. Based on Technology the market is segmented into Electronic, Mechanical.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Artificial Organs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Artificial Organs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Artificial Organs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Artificial Organs market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the Artificial Organs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Artificial Organs market are anticipated to lucrative growth opportunities in the future with the rising demand for Artificial Organs market in the global market. Below mentioned is the list of few companies engaged in the Artificial Organs market.
The report also includes the profiles of Artificial Organs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Organovo Holdings Inc
-Boston Scientific Corporation
-Terumo Corporation
-ABIOMED
-HeartWare
-Cochlear Ltd
-Edwards Lifesciences Corporation.
-Berlin Heart
-Asahi Kasei Medical Co., Ltd
-Thoratec Corporation
(image)